Überblick
Bhanu Sadasivan focuses her practice on patent litigation, with an emphasis in the life sciences industry. She has experience litigating patent cases concerning recombinant DNA technology, pharmaceutical formulation, computer hardware and software.
Prior to law school, she received her PhD in Immunology from Yale University and was a postdoctoral research fellow at Brigham & Women’s Hospital, Harvard Medical School, and was a recipient of the Arthritis Foundation Postdoctoral Fellowship. Bhanu is the co-author of several scientific publications in peer-reviewed journals.
Referenzmandate
- Representing Alnylam in litigation over patents covering lipids and lipid nanoparticles
- Representing Natera in litigation over patents covering methods of preparing DNA
- Represented Quidel in a patent litigation over lateral flow assay method
- Represented Amgen in a patent litigation matter over novel antibody therapeutics for the treatment of high LDL-cholesterol (Amgen v. Sanofi, et al., (D. Delaware))
- Represented Ambry Genetics in an IPR proceeding that resulted in institution of two of the petitions before favorable settlement
- Represented Ambry Genetics in a patent litigation case against Esoterix that resulted in a favorable settlement
- Represented Depomed in a Hatch-Waxman litigation that resulted in the finding that the asserted claims from seven patents were valid and infringed upon
- Represented Ambry Genetics in a patent litigation case against Myriad that resulted in a finding of lack of patentable subject matter under § 101
- Represented APTwater and Stantec Consulting in a patent infringement case that resulted in a favorable claim construction ruling
- Represented 23andMe in litigation over a patent covering a method of finding relative relationships
- Represented Alnylam in a patent infringement case where standing to file a lawsuit was successfully established
Auszeichnungen
- Lawdragon, Top 500 Leading Litigators in America, 2022-2026
- Best Lawyers in America, Litigation – Patent, 2024-2026; Litigation – Intellectual Property, 2025-2026
- IAM Patent 1000, The World’s Leading Patent Practitioners, 2022-2025
- Legal 500 US, Recommended, 2021, 2022 and 2024
- Super Lawyers, 2024-2025; Rising Star, IP litigation, 2013-2014
- Managing Intellectual Property, Patent Star, 2021-2024
- Daily Journal, Top Intellectual Property Lawyer, 2023
- LMG Life Sciences, Shortlisted for General Patent Litigator of the Year – California, 2021; Leading Life Sciences Lawyer, 2022
Mitgliedschaften
- Asian Law Alliance, board member and previous board president
Qualifikation
Education
University of California – Berkeley School of Law, JD
Yale University, PhD, Immunology
All India Institute of Medical Sciences, MS, Immunology, with honors
All India Institute of Medical Sciences, BSc, Human Biology, with honors
Admissions
California
Courts / Agencies
US Court of Appeals for the Federal Circuit
US Court of Appeals for the Ninth Circuit
US District Court for the Central District of California
US District Court for the Northern District of California
US Patent and Trademark Office
Languages
English
Tamil
